4-HO-DIPT

Structural formula
General
Surname	4-HO-DIPT
other names	3- [2- (Diisopropylamino) ethyl] -1 H -indol-4-ol ( IUPAC ) ; 4-hydroxy- N , N -diisopropyltryptamine; Iprocin;
Molecular formula	C 16 H 24 N 2 O
External identifiers / databases
EC number	688-257-0
ECHA InfoCard	100.214.853
PubChem	21854225
ChemSpider	10579819
Wikidata	Q229960
properties
Molar mass	260.38 g · mol -1
safety instructions
GHS labeling of hazardous substances Caution
H and P phrases	H: 302
	P: ?
	As far as possible and customary, SI units are used. Unless otherwise noted, the data given apply to standard conditions .

4-Hydroxy- N , N -diisopropyltryptamine ( 4-HO-DIPT for short ), also Iprocin , is a synthetic tryptamine derivative with a psychedelic effect. It is a designer drug developed by Alexander Shulgin and is structurally related to psilocin , an ingredient in hallucinogenic mushrooms . 4-HO-DIPT is considered to be comparatively short-acting.

Pharmacodynamics

Like all "classic" hallucinogens, 4-HO-DIPT unfolds its effect via the 5-HT _2A receptor as a partial agonist .

Web links

Erowid 4-HO-DiPT Vault. In: erowid.org. June 23, 2004, accessed August 26, 2016 .
Erowid Online Books: "TIHKAL" - # 17 4-HO-DIPT. In: erowid.org. February 21, 2015, accessed August 26, 2016 .

Individual evidence

↑ Template: CL Inventory / not harmonized There is not yet a harmonized classification for this substance . A labeling of [No public or meaningful name is available] in the Classification and Labeling Inventory of the European Chemicals Agency (ECHA), accessed on December 16, 2019, is derived from a self-classification by the distributor .
^ A. Rickli, OD Moning, MC Hoener, ME Liechti: Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens. In: European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology. Volume 26, Number 8, August 2016, pp. 1327-1337, doi : 10.1016 / j.euroneuro.2016.05.001 , PMID 27216487 .

[1] Template: CL Inventory / not harmonized There is not yet a harmonized classification for this substance . A labeling of [No public or meaningful name is available] in the Classification and Labeling Inventory of the European Chemicals Agency (ECHA), accessed on December 16, 2019, is derived from a self-classification by the distributor .

[PMID27216487-2] A. Rickli, OD Moning, MC Hoener, ME Liechti: Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens. In: European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology. Volume 26, Number 8, August 2016, pp. 1327-1337, doi : 10.1016 / j.euroneuro.2016.05.001 , PMID 27216487 .